Manchester International Holdings Unlimited Corporation (MIH) was incorporated as Interphil Laboratories, Inc. on November 6, 1974 primarily to manufacture, process and package drugs, chemicals, pharmaceuticals and veterinary products. On November 21, 2008, the Securities and Exchange Commission (SEC) approved the change in the company's name to its present one. SEC likewise, approved the change in MIH's primary purpose from a manufacturing company to that of a holding company. On July 10, 2008, the stockholders of MIH approved the restructuring of MIH, as proposed by the Board of Directors. The restructuring involves the creation of two new wholly-owned subsidiaries under MIH. The two companies are First Pharma Industries Inc., a toll manufacturing company, later renamed Interphil Laboratories, Inc. (Interphil), and Lancashire Realty Holding Corp. (Lancashire), a realty company. The operating assets of MIH were moved to Interphil while the real estate assets were transferred to Lancashire. These transfers were executed by way of tax-free exchanges following which MIH shall gain absolute control of Interphil and Lancashire. Source: SEC Form 17-A (2008)